Correlation Engine 2.0
Clear Search sequence regions


  • electron (1)
  • gaba (6)
  • humans (1)
  • lactobacillus brevis (4)
  • layer (1)
  • man (1)
  • PML1 (3)
  • research (1)
  • thin (1)
  • Sizes of these terms reflect their relevance to your search.

    In the present research, the production potential of gamma aminobutyric acid (GABA) using Lactobacillus brevis PML1 was investigated. In addition, the microorganism viability was examined in MAN, ROGOSA, and SHARPE (MRS) after undergoing high hydrostatic pressure at 100, 200, and 300 MPa for 5, 10, and 15 min. Response surface methodology (RSM) was applied to optimize the production conditions of GABA as well as the bacteria viability. Analysis of variance (ANOVA) indicated that both the independent variables (pressure and time) significantly influenced the dependent ones (GABA and bacteria viability) (P < 0.05). The optimum extraction conditions to maximize the production of GABA included the pressure of 300 MPa and the time of 15 min. The amount of the compound was quantified using thin-layer chromatography (TLC) and spectrophotometry. For the process optimization, a central composite design (CCD) was created using Design Expert with 5 replications at the center point, whereby the highest content of GABA was obtained to be 397.73 ppm which was confirmed by high performance liquid chromatography (HPLC). Moreover, scanning electron microscopy (SEM) was utilized to observe the morphological changes in the microorganism. The results revealed that not only did have Lactobacillus brevis PML1 the potential for the production of GABA under conventional conditions (control sample) but also the content of this bioactive compound could be elevated by optimizing the production parameters. Copyright © 2022 Atefe Ghafurian Nasab et al.

    Citation

    Atefe Ghafurian Nasab, Sayed Ali Mortazavi, Farideh Tabatabaei Yazdi, Mahboobe Sarabi Jamab. Optimization of Gamma Aminobutyric Acid Production Using High Pressure Processing (HPP) by Lactobacillus brevis PML1. BioMed research international. 2022;2022:8540736

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35071599

    View Full Text